Financials
- Market Capitalization 26.85 M
- Employee 16
- Founded 2013
- CEO N/A
- Website www.lanternpharma.com
- Headquarter Texas, United States
- FIGI BBG00GM6LK17
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.93
Rapporto prezzo/fatturato
-390.6
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4477 | CVM Cel-Sci Corporation Common Stock | 1.54 USD | -4.94% | +5.48% | +27.27% | -70.10% | 27.09 M USD | ||
| 4479 | NNVC NanoViricides, Inc. Common Stock | 1.25 USD | -3.10% | -6.72% | -21.38% | +23.75% | 27.06 M USD | ||
| 4491 | BYSI BeyondSpring, Inc. - Ordinary Shares | 0.63 USD | -1.56% | -16.00% | -47.93% | -64.00% | 25.91 M USD | ||
| 4495 | EVAX Evaxion A/S - American Depositary Share | 3.06 USD | -2.86% | -8.93% | +8.90% | -7.83% | 25.52 M USD |